Compare

NeuroSense Therapeutics Ltd. vs Ocean Biomedical, Inc. vs Aspire-Lakewood Holdings, Inc. vs Semnur Pharmaceuticals, Inc.

Latest annual figures from SEC filings. Each company is shown for its own most recent fiscal year, so period ends can differ. Select a figure to see its full history.

Latest fiscal yearNeuroSense Therapeutics Ltd.
NRSN
Ocean Biomedical, Inc.
OCEALast annual report: year ended 2024-12-31
Aspire-Lakewood Holdings, Inc.
ASBP
Semnur Pharmaceuticals, Inc.
SMNR
Year ended2025-12-312024-12-312025-12-312025-12-31
Revenuen/an/a$6.2Kn/a
Revenue growth (YoY)n/an/an/an/a
Gross marginn/an/a-1.9%n/a
Operating marginn/an/an/mn/a
Net marginn/an/an/mn/a
Net income-$11.12M-$9.48M-$24.48M-$160.42M
EPS (Diluted)-$0.44-$0.34-$16.38-$0.78
Operating cash flow-$7.67M-$4.18M-$4.92M-$5.87M
Free cash flow-$7.68Mn/an/an/a
Cash & equivalents$166.0Kn/an/a$20.0K
Total assets$1.03M$902.0K$1.31M$1.35M
Total liabilities$2.59M$98.52M$7.69M$22.10M
Shareholders' equity-$1.56M-$97.62M-$6.38M-$20.75M
Return on year-end equityn/an/an/an/a
Shares outstanding32.56M34.87M3.53M230.21M

n/a means the company did not report that line under the concept TickerFacts maps, not that it is zero.

Revenue, most recent five fiscal years

Fiscal yearNeuroSense Therapeutics Ltd.Ocean Biomedical, Inc.Aspire-Lakewood Holdings, Inc.Semnur Pharmaceuticals, Inc.
Latestn/an/a$6.2K
Ended 2025-12-31
n/a
1 year earliern/an/an/an/a
2 years earliern/an/an/an/a
3 years earliern/an/an/an/a
4 years earliern/an/an/an/a